CanSino Biologics
IPOPublic · Tianjin, China · Founded 2009 · $10.0M raised
- Headquarters
- Tianjin
- Employees
- 1001–5000
- Founded
- 2009
- Business Model
- B2B
- Website
- cansinotech.com
- Total Funding
- $10.0M
- Last Round
- $10.0M Series BJan 2017
- Rounds
- 2
- Type
- Public
About
Chinese biopharmaceutical company developing and commercializing innovative vaccines for global public health needs.
Summary
CanSino Biologics is a Healthcare company based in Tianjin, China, founded in 2009. It has raised $10.0M in total across 2 rounds, most recently a $10.0M Series B round in Jan 2017. Investors include Lilly Asia Ventures, Qiming VP and SDIC Fund Management.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2020
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...